Design, Syntheses and SAR of Inhibitors Targeting the T315I-ABL Mutation Jianguo Cao1, Kathy Barrett2, Richard M. Fine3, Colleen Gritzen1, John Hood2, Jason Kang3, Dan Lohse2, Chi Ching Mak1, Andrew McPherson1, Glenn Nor - Organic Syntheses - Document - PDFSEARCH.IO

First Page	Meta Content
	Design, Syntheses and SAR of Inhibitors Targeting the T315I-ABL Mutation Jianguo Cao1, Kathy Barrett2, Richard M. Fine3, Colleen Gritzen1, John Hood2, Jason Kang3, Dan Lohse2, Chi Ching Mak1, Andrew McPherson1, Glenn Nor Add to Reading List Document Date: 2006-11-28 17:36:48 Open Document File Size: 80,96 KB Share Result on Facebook City Meeting Atlanta / San Diego / Src Homology / / Company ACS / Discovery Partners International Inc. / Hong Zhu2 TargeGen Inc. / Upstate Cell Signaling Solutions / Pfizer / TargeGen Inc. / Novartis AG / BioPredict Inc. / AstraZeneca / GraphPad Software / / Country United States / / Currency pence / SAR / / Facility Glu-Lys Salt Bridge / / IndustryTerm donor / meta donor / / Organization Charlotte NC / / Person Chi Ching / / Position representative / / ProvinceOrState California / Georgia / / Technology Molecular modeling / X-ray / / SocialTag Piperazines Orphan drugs Pyridines Organofluorides Dasatinib Imatinib Philadelphia chromosome Nilotinib Protein kinase inhibitor Organic chemistry

Design, Syntheses and SAR of Inhibitors Targeting the T315I-ABL Mutation Jianguo Cao1, Kathy Barrett2, Richard M. Fine3, Colleen Gritzen1, John Hood2, Jason Kang3, Dan Lohse2, Chi Ching Mak1, Andrew McPherson1, Glenn NorAdd to Reading List